EE200300378A - Farmatseutiline kompositsioon - Google Patents

Farmatseutiline kompositsioon

Info

Publication number: EE200300378A
Authority: EE; Estonia
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2001-02-16

Application number

EEP200300378A

Other languages

English (en)

Inventor

Schreder Sven

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-16

Filing date

2002-01-23

Publication date

2003-10-15

2002-01-23 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2003-10-15 Publication of EE200300378A publication Critical patent/EE200300378A/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

EEP200300378A 2001-02-16 2002-01-23 Farmatseutiline kompositsioon EE200300378A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10107261A DE10107261B4 (de)	2001-02-16	2001-02-16	Pharmazeutische Zusammensetzung
PCT/EP2002/000609 WO2002072100A2 (en)	2001-02-16	2002-01-23	Pharmaceutical composition containing pde v inhibitors and surfactants

Publications (1)

Publication Number	Publication Date
EE200300378A true EE200300378A (et)	2003-10-15

Family

ID=7674278

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300378A EE200300378A (et)	2001-02-16	2002-01-23	Farmatseutiline kompositsioon

Country Status (21)

Country	Link
US (1)	US20040082600A1 (et)
EP (1)	EP1385521A2 (et)
JP (1)	JP2004519489A (et)
KR (1)	KR20030074822A (et)
CN (1)	CN1649592A (et)
AR (1)	AR032695A1 (et)
BR (1)	BR0207271A (et)
CA (1)	CA2438401A1 (et)
CZ (1)	CZ20032423A3 (et)
DE (1)	DE10107261B4 (et)
EC (1)	ECSP034769A (et)
EE (1)	EE200300378A (et)
HU (1)	HUP0303141A3 (et)
IL (1)	IL157411A0 (et)
MX (1)	MXPA03007318A (et)
PE (1)	PE20021039A1 (et)
PL (1)	PL364467A1 (et)
RU (1)	RU2003127393A (et)
SK (1)	SK11352003A3 (et)
WO (1)	WO2002072100A2 (et)
ZA (1)	ZA200307216B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1817012A2 (en) *	2004-11-24	2007-08-15	Merck & Co., Inc.	Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
WO2013109354A2 (en) *	2011-12-07	2013-07-25	Texas Southern University	Etravirine formulations and uses thereof
JP6943384B2 (ja) *	2017-03-01	2021-09-29	ヱスビー食品株式会社	食品の食感劣化防止用ソフトカプセル、並びに、該食感劣化防止用ソフトカプセル及び食用油を含有する食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL102003A0 (en) *	1991-06-03	1992-12-30	Merck Sharp & Dohme	Pharmaceutical formulation of a benzodiazepine
DE19819023A1 (de) *	1998-04-29	1999-11-04	Merck Patent Gmbh	Thienopyrimidine
DE19928146A1 (de) *	1999-06-19	2000-12-21	Merck Patent Gmbh	Thienopyrimidine
US20030153585A1 (en) *	2000-01-13	2003-08-14	Sven-Alexander Schreder	Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
DE10001021A1 (de) *	2000-01-13	2001-07-19	Merck Patent Gmbh	Pharmazeutische Zubereitung

2001
- 2001-02-16 DE DE10107261A patent/DE10107261B4/de not_active Expired - Fee Related
2002
- 2002-01-23 WO PCT/EP2002/000609 patent/WO2002072100A2/en not_active Ceased
- 2002-01-23 CA CA002438401A patent/CA2438401A1/en not_active Abandoned
- 2002-01-23 CZ CZ20032423A patent/CZ20032423A3/cs unknown
- 2002-01-23 HU HU0303141A patent/HUP0303141A3/hu unknown
- 2002-01-23 BR BR0207271-8A patent/BR0207271A/pt not_active IP Right Cessation
- 2002-01-23 US US10/467,788 patent/US20040082600A1/en not_active Abandoned
- 2002-01-23 RU RU2003127393/15A patent/RU2003127393A/ru not_active Application Discontinuation
- 2002-01-23 SK SK1135-2003A patent/SK11352003A3/sk not_active Application Discontinuation
- 2002-01-23 EE EEP200300378A patent/EE200300378A/et unknown
- 2002-01-23 JP JP2002571059A patent/JP2004519489A/ja not_active Withdrawn
- 2002-01-23 CN CNA028050061A patent/CN1649592A/zh active Pending
- 2002-01-23 EP EP02701263A patent/EP1385521A2/en not_active Withdrawn
- 2002-01-23 KR KR10-2003-7010607A patent/KR20030074822A/ko not_active Withdrawn
- 2002-01-23 PL PL02364467A patent/PL364467A1/xx unknown
- 2002-01-23 IL IL15741102A patent/IL157411A0/xx unknown
- 2002-01-23 MX MXPA03007318A patent/MXPA03007318A/es unknown
- 2002-02-15 AR ARP020100516A patent/AR032695A1/es not_active Application Discontinuation
- 2002-02-15 PE PE2002000135A patent/PE20021039A1/es not_active Application Discontinuation
2003
- 2003-09-15 EC EC2003004769A patent/ECSP034769A/es unknown
- 2003-09-15 ZA ZA200307216A patent/ZA200307216B/en unknown

Also Published As

Publication number	Publication date
EP1385521A2 (en)	2004-02-04
ECSP034769A (es)	2003-12-24
SK11352003A3 (sk)	2003-12-02
AR032695A1 (es)	2003-11-19
CA2438401A1 (en)	2002-09-19
US20040082600A1 (en)	2004-04-29
ZA200307216B (en)	2005-01-13
DE10107261A1 (de)	2002-09-12
DE10107261B4 (de)	2005-03-10
BR0207271A (pt)	2004-03-23
PL364467A1 (en)	2004-12-13
WO2002072100A3 (en)	2003-11-06
MXPA03007318A (es)	2003-12-04
IL157411A0 (en)	2004-03-28
HUP0303141A2 (hu)	2003-12-29
HUP0303141A3 (en)	2006-05-29
PE20021039A1 (es)	2002-11-14
KR20030074822A (ko)	2003-09-19
JP2004519489A (ja)	2004-07-02
CZ20032423A3 (en)	2004-07-14
WO2002072100A2 (en)	2002-09-19
RU2003127393A (ru)	2005-01-20
CN1649592A (zh)	2005-08-03

Publication	Publication Date	Title
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
PL367180A1 (pl)	2005-02-21	Trwała kompozycja farmaceutyczna
EE200300416A (et)	2003-12-15	Ravimvorm
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
IS7051A (is)	2003-11-26	Lyfjasamsetningar
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
NO20031095L (no)	2003-03-10	Farmasoytiske sammensetninger
DE60217390D1 (de)	2007-02-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
IS7581A (is)	2004-12-03	Lyfjasamsetning
EE200300378A (et)	2003-10-15	Farmatseutiline kompositsioon
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS
EE200200689A (et)	2004-06-15	Ravimkoostised
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus
SE0100847D0 (sv)	2001-03-09	Novel pharmaceutical composition